Oct 27 2014
Thermomedics, Inc, a division of Sanomedics announced that its Caregiver® TouchFree™ Clinical Thermometer was awarded the coveted Innovative Technology designation by Novation at its Innovative Technology Expo on Sept. 10, 2014, at the Irving Convention Center, Irving, Texas.
The Only Clinical Grade Non Contact IR Thermometer
The Caregiver does not require probe-covers, since it does not contact the patient, making it ideal for reducing risk of transmission of infectious disease. It takes temperature in 1-2 seconds and is easy-to-use with minimal inservice. The lack of probe covers also contributes to reduction of plastic waste and reduces costs for storage, as well.
The Caregiver was awarded the Innovative Technology designation following a review by more than 200 attendees from hospitals around the United States who serve on a Novation council or task force and participated in the Expo. These key opinion leaders indicated the Thermomedics Caregiver device offered incremental benefit over other products available on the market.
Olya Carter, RN and Senior Clinical Manager at Novation said, "Hospital participants strongly supported the Thermomedics Caregiver TouchFree Thermometer. They identified the Caregiver as the way to provide superior patient care by allowing them to efficiently assess their patients in the safest possible way."
Keith Houlihan, Company President, noted that "this medical instrument is a breakthrough in patient care and reduces costs, time and technique-dependence while upgrading standards of practice. Our TouchFree technology is the world leader in contagion risk avoidance."
This new designation will also identify Thermomedics' Caregiver® TouchFree™ Clinical Thermometer as an awarded Innovative Technology product within Novation's online contract catalog, which is accessible by the more than 100,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association, and Provista served by Novation. This heightened visibility will encourage further consideration by members accessing this agreement.